TW356468B - Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same - Google Patents

Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same

Info

Publication number
TW356468B
TW356468B TW085111075A TW85111075A TW356468B TW 356468 B TW356468 B TW 356468B TW 085111075 A TW085111075 A TW 085111075A TW 85111075 A TW85111075 A TW 85111075A TW 356468 B TW356468 B TW 356468B
Authority
TW
Taiwan
Prior art keywords
same
adrenoreceptor
beta2
dopamine
pharmaceutical compositions
Prior art date
Application number
TW085111075A
Other languages
English (en)
Inventor
Roger Victor Bonnert
Roger Charles Brown
Peter Alan Cage
Francis Ince
Garry Pairaudeau
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518952.8A external-priority patent/GB9518952D0/en
Priority claimed from GBGB9614346.6A external-priority patent/GB9614346D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Application granted granted Critical
Publication of TW356468B publication Critical patent/TW356468B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
TW085111075A 1995-09-15 1996-09-11 Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same TW356468B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518952.8A GB9518952D0 (en) 1995-09-15 1995-09-15 Compounds
GBGB9614346.6A GB9614346D0 (en) 1996-07-10 1996-07-10 Benzothiazolone derivatives

Publications (1)

Publication Number Publication Date
TW356468B true TW356468B (en) 1999-04-21

Family

ID=26307771

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085111075A TW356468B (en) 1995-09-15 1996-09-11 Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same

Country Status (29)

Country Link
US (5) US5846989A (zh)
EP (1) EP0850232B1 (zh)
JP (1) JP3213327B2 (zh)
KR (1) KR19990044674A (zh)
CN (2) CN1073098C (zh)
AR (1) AR004512A1 (zh)
AT (1) ATE190610T1 (zh)
AU (1) AU706094B2 (zh)
BR (1) BR9610316A (zh)
CA (1) CA2231003A1 (zh)
CY (1) CY2227B1 (zh)
CZ (1) CZ74098A3 (zh)
DE (1) DE69607183T2 (zh)
EE (1) EE03395B1 (zh)
ES (1) ES2146901T3 (zh)
GR (1) GR3033681T3 (zh)
HK (1) HK1008781A1 (zh)
HU (1) HUP9802393A3 (zh)
IL (4) IL141955A0 (zh)
IS (1) IS4679A (zh)
MY (1) MY113518A (zh)
NO (1) NO310721B1 (zh)
NZ (4) NZ318007A (zh)
PL (1) PL325517A1 (zh)
PT (1) PT850232E (zh)
SK (1) SK282394B6 (zh)
TR (1) TR199800457T2 (zh)
TW (1) TW356468B (zh)
WO (1) WO1997010227A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU742506B2 (en) * 1997-10-17 2002-01-03 Eurogene Limited The use of inhibitors of the renin-angiotensin system
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
CA2543858C (en) * 2003-11-21 2014-04-15 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
UA94235C2 (en) * 2005-08-09 2011-04-26 Астразенека Аб Novel benzothiazolone derivatives
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
US20100056508A1 (en) * 2006-12-20 2010-03-04 Astrazeneca Ab Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
WO2009154557A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
EP2303266A4 (en) * 2008-06-20 2015-01-21 Astrazeneca Ab PHARMACEUTICAL COMPOSITION COMPRISING A 4-HYDROXY-2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-7-YLE COMPOUND FOR THE MODULATION OF BETA-2-ADRENORECEPTOR ACTIVITY

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
DK514585A (da) * 1984-11-08 1986-05-09 Syntex Inc Aminoethylanilinderivater
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds

Also Published As

Publication number Publication date
EP0850232B1 (en) 2000-03-15
IL123639A (en) 2002-04-21
IL123639A0 (en) 1998-10-30
WO1997010227A1 (en) 1997-03-20
NO981104L (no) 1998-05-14
KR19990044674A (ko) 1999-06-25
NO310721B1 (no) 2001-08-20
AU6937196A (en) 1997-04-01
HUP9802393A3 (en) 2000-01-28
CA2231003A1 (en) 1997-03-20
NZ332395A (en) 1999-02-25
BR9610316A (pt) 1999-07-06
CN1202163A (zh) 1998-12-16
DE69607183T2 (de) 2000-11-23
MY113518A (en) 2002-03-30
SK29598A3 (en) 1999-01-11
NZ332396A (en) 1999-02-25
PT850232E (pt) 2000-08-31
EE03395B1 (et) 2001-04-16
US6008365A (en) 1999-12-28
US6080869A (en) 2000-06-27
AU706094B2 (en) 1999-06-10
JP3213327B2 (ja) 2001-10-02
EP0850232A1 (en) 1998-07-01
US5973167A (en) 1999-10-26
US5977384A (en) 1999-11-02
ES2146901T3 (es) 2000-08-16
TR199800457T2 (xx) 1998-07-21
IS4679A (is) 1998-03-04
AR004512A1 (es) 1998-12-16
MX9801963A (es) 1998-08-30
NO981104D0 (no) 1998-03-12
CY2227B1 (en) 2003-04-18
ATE190610T1 (de) 2000-04-15
PL325517A1 (en) 1998-08-03
HUP9802393A2 (hu) 1999-04-28
IL141954A0 (en) 2002-03-10
CZ74098A3 (cs) 1998-08-12
DE69607183D1 (de) 2000-04-20
IL141955A0 (en) 2002-03-10
US5846989A (en) 1998-12-08
HK1008781A1 (en) 1999-05-21
SK282394B6 (sk) 2002-01-07
NZ318007A (en) 1999-07-29
NZ332397A (en) 1999-02-25
IL141956A0 (en) 2002-03-10
GR3033681T3 (en) 2000-10-31
EE9800069A (et) 1998-10-15
JPH11512422A (ja) 1999-10-26
CN1073098C (zh) 2001-10-17
CN1356323A (zh) 2002-07-03

Similar Documents

Publication Publication Date Title
TW356468B (en) Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
TW342390B (en) Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
CA2036876A1 (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NZ238181A (en) N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
EA200000023A1 (ru) Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
HUT67259A (en) 5-amino-8-methyl-7-pyrrolidinyl-quinoline-3-carboxylic acid derivatives and pharmaceutical compositions containing them
HUP9903459A2 (hu) Oxa- és tiabiciklo[3.1.0]hexán-karbonsavak, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HK1019334A1 (en) 2-(arylphenyl) amino-imidazoline derivatives
ATE142213T1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
CA2292921A1 (en) Aryl carboxylic acid and tetrazole derivatives
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
TW427973B (en) Novel compounds as excitatory amino acid receptor antagonists, process for the preparation thereof, and pharmaceutical compositions comprising the compounds
CA2030732A1 (fr) Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
AU631498B2 (en) New acylbenzoxazolinones, process for preparing them and pharmaceutical compositions containing them
MX9600816A (es) Nuevos derivados triciclicos, su preparacion, su aplicacion a la preparacion de la colquicina y de la tiocolquicina, opticamente activas o racemicas, y de compuestos analogos o derivados e intermedios.
HU9503775D0 (en) Benzene derivative useful for ischemic diseases
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
HRP20050617A2 (en) Imidazol derivatives having affinity for alpha 2 receptors activity
HU886767D0 (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
HUP0303691A2 (hu) Uretánszármazékok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására
KR970027083A (ko) 페넴 유도체 및 이의 제조방법